Trials / Completed
CompletedNCT01770431
Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy
A Multicenter, Randomized, Paralleled Control Clinical Study Investigating Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,044 (actual)
- Sponsor
- Qidong Gaitianli Medicines Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of Huaier Granule for prevention of recurrence and metastasis of hepatocarcinoma after radical hepatectomy.
Detailed description
A Multicenter, Randomized, Paralleled control Clinical Study Investigating Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma after Radical Hepatectomy,to evaluate the efficacy and safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Huaier Granule | Huaier Granule is a traditional Chinese medicine, 20g / time, 3 times/day,Po. |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2013-01-17
- Last updated
- 2017-10-02
- Results posted
- 2017-10-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01770431. Inclusion in this directory is not an endorsement.